Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Slides:

Advertisements

Similar presentations

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Advertisements

Results of surgical treatment of adenocarcinoma of the gastric cardia

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

Short- and Long-Term Outcomes after Large Pulmonary Resection for Germ Cell Tumors After Bleomycin-Combination Chemotherapy Rafael S. Andrade, MD, Kenneth.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients Joachim Pfannschmidt,

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma Sina Ercan, MD, Francis C Nichols,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Castigliano M. Bhamidipati, DO, MS, George J

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum Kenneth A. Kesler, MD, Laura E. Kruter,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer Jung-Jyh Hung, MD,

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Prognostic factors in clinical stage I non–small cell lung cancer

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Long-term results after pulmonary resection of renal cell carcinoma metastases Stefan Piltz, MD, Georgios Meimarakis, MD, Matthias W Wichmann, MD, Rudolf.

A Pragmatic Approach to the Diagnosis of Nodal Micrometastases in Early Stage Non- small Cell Lung Cancer Esther Herpel, MD, Thomas Muley, PhD, Thomas.

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Importance of Lymph Node Dissection in Thymic Carcinoma

Is surgery for multiple lung metastases reasonable

Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.

Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine.

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,

Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Florian Loehe, MD, Sonja Kobinger, MD, Rudolf A Hatz, MD, Thomas.

Pulmonary Resection for Metastases from Colorectal Cancer

Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD, John C

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection Shiro Nagatani, MD, Yutaka Shimada,

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

Carcinoma of the esophagus: Prognostic significance of histologic type

The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma Tara A. Waterman, BA, Jeffrey A. Hagen,

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Is there a role for pneumonectomy in pulmonary metastases?1

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Marc Riquet, MD, PhD, Patrick Bagan,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Surgery for pulmonary metastases from colorectal carcinoma

Presentation transcript:

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas Muley, PhD, Sabine Krysa, MD, Christine Trainer, MD, Hendrik Dienemann, MD, PhD The Annals of Thoracic Surgery Volume 74, Issue 5, Pages 1653-1657 (November 2002) DOI: 10.1016/S0003-4975(02)03803-1

Fig 1 Probability of survival (death from any cause) of patients after pulmonary resection of metastatic renal cell carcinoma: complete resection (R0) versus incomplete resection (R1 or R2). Zero time on the abscissa represents the date of pulmonary resection (p = 0.049, log-rank test). The Annals of Thoracic Surgery 2002 74, 1653-1657DOI: (10.1016/S0003-4975(02)03803-1)

Fig 2 Survival curves after complete resection by the presence of one, two, or three of the following independent significant risk factors (RF) for survival that were identified by multivariate analysis: disease-free interval ≤23 months, number of metastases more than seven, and presence of lymph node metastasis. Zero time on the abscissa represents the date of pulmonary resection (log-rank test). The Annals of Thoracic Surgery 2002 74, 1653-1657DOI: (10.1016/S0003-4975(02)03803-1)

Fig 3 Probability of survival (death from any cause) of patients undergoing a single thoracotomy for renal cell carcinoma metastatic to the lung as compared with patients who underwent multiple thoracotomies for recurrent renal cell carcinoma to the lungs (survival starting at the first operation). Zero time on the abscissa represents the date of the first thoracotomy (p = 0.11, log-rank test). The Annals of Thoracic Surgery 2002 74, 1653-1657DOI: (10.1016/S0003-4975(02)03803-1)